248 related articles for article (PubMed ID: 16804507)
1. Series of seizures as a sign of development of recurrent malignant neuroleptic syndrome - a case report.
Supe S; Matijević V; Kondić L; Alvir D
Psychiatr Danub; 2006 Jun; 18(1-2):97-101. PubMed ID: 16804507
[TBL] [Abstract][Full Text] [Related]
2. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
3. Atypical (olanzapine) plus conventional (fluphenazine) neuroleptic treatment associated with the neuroleptic malignant syndrome.
Tofler IT; Ahmed B
J Clin Psychopharmacol; 2003 Dec; 23(6):672-4. PubMed ID: 14624203
[No Abstract] [Full Text] [Related]
4. Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.
Järventausta K; Leinonen E
Acta Psychiatr Scand; 2000 Sep; 102(3):231-3. PubMed ID: 11008860
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic malignant syndrome due to olanzapine.
Hall KL; Taylor WH; Ware MR
Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
[TBL] [Abstract][Full Text] [Related]
6. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
Khouri C; Planès S; Logerot S; Villier C; Mallaret M
Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine-associated neuroleptic malignant syndrome.
Norgard NB; Stark JE
Pharmacotherapy; 2006 Aug; 26(8):1180-2. PubMed ID: 16863495
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
Srivastava A; Borkar HA; Chandak S
Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992
[TBL] [Abstract][Full Text] [Related]
9. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
Liu PY; Wu PC; Chen CY; Chen YC
Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
[TBL] [Abstract][Full Text] [Related]
10. Atypical neuroleptic malignant syndrome caused by olanzapine.
Nielsen J; Bruhn AM
Acta Psychiatr Scand; 2005 Sep; 112(3):238-40; discussion 240. PubMed ID: 16095481
[TBL] [Abstract][Full Text] [Related]
11. [Neuroleptic malignant syndrome. Case reports].
Berardi D; Troia M; Veronesi L; Ferrari G
Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine induced neuroleptic malignant syndrome--a case review.
Kogoj A; Velikonja I
Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
[TBL] [Abstract][Full Text] [Related]
13. Atypicality in presentation of neuroleptic malignant syndrome caused by olanzapine.
Mishra B; Mishra B; Sahoo S; Arora M; Khess CR
Indian J Med Sci; 2007 Oct; 61(10):570-3. PubMed ID: 17932448
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic malignant syndrome presenting without initial fever: a case report.
Totten VY; Hirschenstein E; Hew P
J Emerg Med; 1994; 12(1):43-7. PubMed ID: 8163804
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome.
Lee JW
J Clin Psychopharmacol; 2010 Feb; 30(1):3-10. PubMed ID: 20075641
[TBL] [Abstract][Full Text] [Related]
17. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
Lee JW
Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
[TBL] [Abstract][Full Text] [Related]
19. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
[TBL] [Abstract][Full Text] [Related]
20. [Polytrauma and malignant neuroleptic syndrome. Case presentation with diagnostic problems].
Röther J; Jakob J; Bender HJ; Hewer W
Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Nov; 30(7):455-7. PubMed ID: 8562725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
